RT @RichardPAConway: Dr Lillegraven presents a randomized open-label phase 4, non-Inferiority trial of TNFi tapering in
Tweet Content
Dr Lillegraven presents a randomized open-label phase 4, non-Inferiority trial of TNFi tapering in RA patients in sustained remission. 63% of tapered patients flared over 12 months vs 5% of maintained. Good response to reintroduction of TNFi @rheumnow #ACR20 Abstr#2010 https://t.co/Ki7PTsetbH
Show on Archive Page
On
Display in Search Results
On